受强制性开放获取政策约束的文章 - Vincent van Pesch了解详情
无法在其他位置公开访问的文章：8 篇
Predictors and dynamics of postpartum relapses in women with multiple sclerosis
SE Hughes, T Spelman, OM Gray, C Boz, M Trojano, A Lugaresi, ...
Multiple Sclerosis Journal 20 (6), 739-746, 2014
强制性开放获取政策： UK Medical Research Council
Extracellular vesicles for the treatment of central nervous system diseases
V Gratpain, A Mwema, Y Labrak, GG Muccioli, V Van Pesch, A des Rieux
Advanced drug delivery reviews 174, 535-552, 2021
强制性开放获取政策： National Fund for Scientific Research, Belgium
Effects of fampridine in people with multiple sclerosis: a systematic review and meta-analysis
M Valet, M Quoilin, T Lejeune, G Stoquart, V Van Pesch, S El Sankari, ...
CNS drugs 33, 1087-1099, 2019
强制性开放获取政策： National Fund for Scientific Research, Belgium
Regulation of Treg-associated CD39 in multiple sclerosis and effects of corticotherapy during relapse
NGV Muls, HA Dang, CJM Sindic, V Van Pesch
Multiple Sclerosis Journal 21 (12), 1533-1545, 2015
强制性开放获取政策： National Fund for Scientific Research, Belgium
Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program
V Van Pesch, E Bartholomé, V Bissay, O Bouquiaux, M Bureau, ...
Acta neurologica belgica 114, 167-178, 2014
强制性开放获取政策： Research Foundation (Flanders)
Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network
A Signori, J Lorscheider, S Vukusic, M Trojano, P Iaffaldano, J Hillert, ...
Journal of Neurology, Neurosurgery & Psychiatry 94 (1), 23-30, 2023
强制性开放获取政策： National Health and Medical Research Council, Australia, Canadian Institutes …
Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis
C Zhu, Z Zhou, I Roos, D Merlo, T Kalincik, S Ozakbas, O Skibina, J Kuhle, ...
Journal of Neurology, Neurosurgery & Psychiatry 93 (12), 1330-1337, 2022
强制性开放获取政策： National Health and Medical Research Council, Australia
The combined administration of LNC-encapsulated retinoic acid and calcitriol stimulates oligodendrocyte progenitor cell differentiation in vitro and in vivo after intranasal …
Y Labrak, M Alhouayek, A Mwema, L d’Auria, B Ucakar, V Van Pesch, ...
International Journal of Pharmaceutics 659, 124237, 2024
强制性开放获取政策： National Fund for Scientific Research, Belgium
可在其他位置公开访问的文章：88 篇
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
CE Teunissen, A Petzold, JL Bennett, FS Berven, L Brundin, M Comabella, ...
Neurology 73 (22), 1914-1922, 2009
强制性开放获取政策： US National Institutes of Health
Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis
JWL Brown, A Coles, D Horakova, E Havrdova, G Izquierdo, A Prat, ...
Jama 321 (2), 175-187, 2019
强制性开放获取政策： National Health and Medical Research Council, Australia, UK Medical Research …
Defining secondary progressive multiple sclerosis
J Lorscheider, K Buzzard, V Jokubaitis, T Spelman, E Havrdova, ...
Brain 139 (9), 2395-2405, 2016
强制性开放获取政策： National Health and Medical Research Council, Australia
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study
A He, B Merkel, JWL Brown, LZ Ryerson, I Kister, CB Malpas, S Sharmin, ...
The Lancet Neurology 19 (4), 307-316, 2020
强制性开放获取政策： National Health and Medical Research Council, Australia, National Institute …
Geographical variations in sex ratio trends over time in multiple sclerosis
M Trojano, G Lucchese, G Graziano, BV Taylor, S Simpson Jr, V Lepore, ...
PloS one 7 (10), e48078, 2012
强制性开放获取政策： Canadian Institutes of Health Research
Defining reliable disability outcomes in multiple sclerosis
T Kalincik, G Cutter, T Spelman, V Jokubaitis, E Havrdova, D Horakova, ...
Brain 138 (11), 3287-3298, 2015
强制性开放获取政策： National Health and Medical Research Council, Australia
Predictors of long‐term disability accrual in relapse‐onset multiple sclerosis
VG Jokubaitis, T Spelman, T Kalincik, J Lorscheider, E Havrdova, ...
Annals of neurology 80 (1), 89-100, 2016
强制性开放获取政策： National Health and Medical Research Council, Australia
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis
T Kalincik, V Vivek, V Jokubaitis, J Lechner-Scott, M Trojano, G Izquierdo, ...
Brain 136 (12), 3609-3617, 2013
强制性开放获取政策： National Health and Medical Research Council, Australia
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
T Kalincik, JWL Brown, N Robertson, M Willis, N Scolding, CM Rice, ...
The Lancet Neurology 16 (4), 271-281, 2017
强制性开放获取政策： National Health and Medical Research Council, Australia, UK Medical Research …
Paramagnetic rim lesions are specific to multiple sclerosis: an international multicenter 3T MRI study
P Maggi, P Sati, G Nair, ICM Cortese, S Jacobson, BR Smith, A Nath, ...
Annals of neurology 88 (5), 1034-1042, 2020
强制性开放获取政策： US National Institutes of Health
Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis
A He, T Spelman, V Jokubaitis, E Havrdova, D Horakova, M Trojano, ...
JAMA neurology 72 (4), 405-413, 2015
强制性开放获取政策： National Health and Medical Research Council, Australia
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response
T Kalincik, A Manouchehrinia, L Sobisek, V Jokubaitis, T Spelman, ...
Brain 140 (9), 2426-2443, 2017
强制性开放获取政策： National Health and Medical Research Council, Australia
出版信息和资助信息由计算机程序自动确定